Steris reported 5.4% organic revenue growth and 7% adjusted EPS growth, driven by a 7.2% increase in AST business. See why I reiterate my hold rating on STE stock.
Steris reported 5.4% organic revenue growth and 7% adjusted EPS growth, driven by a 7.2% increase in AST business. See why I reiterate my hold rating on STE stock.
